Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.700
+0.370 (8.55%)
At close: Jun 26, 2026, 4:00 PM EDT
4.564
-0.136 (-2.90%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Passage Bio Employees
Passage Bio had 24 employees as of December 31, 2025. The number of employees decreased by 36 or -60.00% compared to the previous year.
Employees
24
Change (1Y)
-36
Growth (1Y)
-60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,569,833
Market Cap
15.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 24 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| Atossa Therapeutics | 16 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
| Lexaria Bioscience | 7 |
| Traws Pharma | 7 |
PASG News
- 2 days ago - Passage Bio trading resumes - TheFly
- 2 days ago - Passage Bio Transcript: M&A announcement - Transcripts
- 2 days ago - Passage Bio Press release: M&A announcement - Filings
- 2 days ago - Passage Bio, Remix Therapeutics to combine in all-stock transaction - TheFly
- 2 days ago - Passage Bio trading halted, news pending - TheFly
- 2 days ago - Passage Bio and Remix Therapeutics Announce Merger Agreement - GlobeNewsWire
- 16 days ago - Guggenheim downgrades Passage Bio to Neutral, terminates coverage - TheFly
- 16 days ago - Passage Bio downgraded to Neutral from Buy at Guggenheim - TheFly